Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
JAMES BRUCE TANANBAUM
AddedFeb 20, 2024
UpdatedJun 28, 2026
JAMES BRUCE TANANBAUM

JAMES BRUCE TANANBAUM

Founder, Foresite Capital

CrunchbaseLinkedInThe Org

JAMES BRUCE TANANBAUM's Career

Foresite Capital
Foresite Capital

San Francisco, CA, US

Founder
GelTex Pharmaceuticals
GelTex Pharmaceuticals

Waltham, MA, US

Co-Founder
Element Biosciences
Element Biosciences

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

JAMES BRUCE TANANBAUM's Career

Foresite Capital
Foresite Capital
Investment FirmInvestment Firm682011San Francisco, CA, US
Founder
GelTex Pharmaceuticals
GelTex Pharmaceuticals
Acquired$6.8M01992Waltham, MA, US
Co-Founder

Leadership at GelTex Pharmaceuticals

Bob CarpenterBob CarpenterCo-Founder
George WhitesidesGeorge WhitesidesCo-Founder

Similar to GelTex Pharmaceuticals

GlycologixGlycologixBeverly, MA, USBiomaterials, Therapiesest. 2016GlycologixBeverly, MA, US · est. 2016

Glycologix: A biotech firm specializing in R&D for soft tissue protection and repair.

Pre-Seed · $2.9M6
Tega TherapeuticsTega TherapeuticsLos Angeles, CA, USPharmaceuticalsest. 2014Tega TherapeuticsLos Angeles, CA, US · est. 2014

TEGA Therapeutics: A pharmaceutical leader in glycan science, enhancing lives with innovative treatments.

Public · $1.5M5
GelSana TherapeuticsGelSana TherapeuticsAurora, CO, USWound Careest. 2020GelSana TherapeuticsAurora, CO, US · est. 2020

GelSana Therapeutics: Innovating wound healing with advanced hydrogel products.

Seed · $4.2M5
Galmed PharmaceuticalsGalmed PharmaceuticalsTel Aviv, Tel Aviv District, ILPharmaceuticalsest. 2000Galmed PharmaceuticalsTel Aviv, Tel Aviv District, IL · est. 2000

Tel Aviv-based Galmed Pharmaceuticals develops and commercializes treatments for liver diseases and cholesterol gallstones.

Public · $103.6M24
Element Biosciences
Element Biosciences
Series C$401M3482017San Diego, CA, US
Board Member· Board

Leadership at Element Biosciences

Bryan RobertsBryan RobertsBoard Member
Molly HeMolly HeBoard Member
Michael PreviteMichael PreviteCo-Founder
John StuelpnagelJohn StuelpnagelBoard Member

Similar to Element Biosciences

Pacific Biosciences of CaliforniaPacific Biosciences of CaliforniaMenlo Park, CA, USGenetic Analysis, Sequencing Systemsest. 2004Pacific Biosciences of CaliforniaMenlo Park, CA, US · est. 2004

Pacific Biosciences, a CA-based medical firm, designs and manufactures sequencing systems for complex genetic analysis.

Public · $2B769
BioDatomicsBioDatomicsBethesda, MD, USSoftwareest. 2010BioDatomicsBethesda, MD, US · est. 2010

BioDatomics: Advanced software tool for omics research, simplifying complex bio-research since 2010.

Seed · $1.5M30
BioSkryb GenomicsBioSkryb GenomicsDurham, NC, USGenomic Toolsest. 2018BioSkryb GenomicsDurham, NC, US · est. 2018

BioSkryb Genomics: Transforming single cell discovery with advanced genomic tools for disease management.

Series A · $31.5M83
Singular GenomicsSingular GenomicsSan Diego, CA, USGenomic Technologiesest. 2016Singular GenomicsSan Diego, CA, US · est. 2016

Singular Genomics: A dynamic, fast-paced biotech company in California, innovating in genomic technologies.

Public · $176M134

JAMES BRUCE TANANBAUM's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · Dunamu

People Similar to JAMES BRUCE TANANBAUM

Jim TananbaumJim TananbaumBoard Member · Fulcrum TherapeuticsCindy XiongCindy XiongBoard Member · Immpact BioAlexey ChetvergovAlexey ChetvergovFounder · Fores VenturesForest BaiForest BaiCo-Founder · Foresight VenturesTodd DipaolaTodd DipaolaFounder · InMarketDavid FontainDavid FontainCo-Founder & CEO · Foresight